Cancer patients skip treatments as drug costs rise sbne.ws/r/wylE
Novartis sets price for Kisqali below Ibrance sbne.ws/r/wxEh
Amgen's Repatha Meets Primary Endpoint in Phase III Study finance.yahoo.com/news/amgen… via @YahooFinance
Rolling the dice on a hepatitis C-tainted liver bostonglobe.com/metro/2017/0… via @BostonGlobe
Specialty Pharmacy Dispute With Express Scripts Rages Over Network Removal - goo.gl/alerts/65pij
Avella Specialty Pharmacy Issues Voluntary Nationwide Recall of all Sterile Products Produced at - goo.gl/alerts/HU66s
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not al - goo.gl/alerts/0CX5h
Modern day insurance Goliath, OptumRX sued - goo.gl/alerts/tU4dG
Fall Lupus Summit coming to Cleveland news-herald.com/article/HR/2… via @newsheraldinoh
Golimumab Effective for Early Peripheral Spondyloarthritis medscape.com/viewarticle/868… via @medscape
Horizon to fork over $65M to settle Express Scripts rebate clash fiercepharma.com/pharma/hori…
Express Scripts gets subpoenas over drug company, pharmacy ties - goo.gl/alerts/jcsym
Shire bails out of Baxalta biosimilars, ends Coherus, Momenta deals - goo.gl/alerts/ciEEU
CABOMETYXTM (Cabozantinib) Tablets Approved for Advanced Renal Cell Carcinoma, Available ... - goo.gl/alerts/SrlgD
Rx30 and Computer-Rx Announce Strategic Combination - goo.gl/alerts/t3eiS
Alecensa Granted Second Breakthrough Therapy Designation for Lung Cancer - goo.gl/alerts/ghhT6
Enbrel Biosimilar Gains FDA Approval - goo.gl/alerts/hQeas
Mylan's (MYL) Epipen4Schools Program is a Complicated Maze streetinsider.com/Analyst+Co… via @Street_Insider
